Bosentan for increased pulmonary vascular resistance in a patient with single ventricle physiology and a bidirectional Glenn shunt

Pediatric Cardiology

Volumn 28, Issue 4, 2007, Pages 314-316

  Votava Smith, J K ^a   Perens, G S ^a   Alejos, J C ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Bosentan; Congenital heart disease; Glenn; Pulmonary hypertension

Indexed keywords

BOSENTAN; FUROSEMIDE; LISINOPRIL;

ARTICLE; CARDIOPULMONARY EXERCISE TEST; CASE REPORT; DRUG DOSE INCREASE; EXERCISE TEST; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART VENTRICLE; HUMAN; LUNG ARTERY BANDING; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OXYGEN CONSUMPTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; ARTERIOVENOUS SHUNT, SURGICAL; CARDIAC SURGICAL PROCEDURES; CHILD; EXERCISE TEST; EXERCISE TOLERANCE; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; MALE; OXYGEN CONSUMPTION; PULMONARY ARTERY; SULFONAMIDES; VASCULAR RESISTANCE;

EID: 34250852335     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-0037-4     Document Type: Article

References (12)

1. Alejos JC, Williams RG, Jarmakani JM, et al. (1995) Factors influencing survival in patients undergoing the bidirectional Glenn anastamosis. Am J Cardiol 75:1048-1050
2. Fratz S, Geiger R, Kresse H, et al. (2003) Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance. J Thorac Cardiovasc Surg 126:1724-1729
3. Galie N, Beghetti M, Gatzoulis MA, et al. (2006) Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 114:48-54
4. Granton JT, Rabinovitch M (2002) Pulmonary arterial hypertension in congenital heart disease. Cardiol Clin 20:441-457, vii
5. Lutz J, Gorenflo M, Habighorst M, Vogel M, Lange PE, Hocher B (1999) Endothelin-1- and endothelin-receptors in lung biopsies of patients with pulmonary hypertension due to congenital heart disease. Clin Chem Lab Med 37:423-428
6. Maiya S, Hislop AA, Flynn Y, Haworth SG (2006) Response to bosentan in children with pulmonary hypertension 92:664-670
7. Mayer JE (2006) Surgical management of the patient with the univentricular heart. In: Keane JF, Lock JE, Fyler DC (eds.) Nadas' Pediatric Cardiology, 2nd ed. Saunders, Philadelphia, pp 863-868
8. Pridjian AK, Mendelsohn AM, Lupinetti FM, et al. (1993) Usefulness of the bidirectional Glenn procedure as a staged reconstruction for the functional single ventricle. Am J Cardiol 71:959-962
9. Rosenzweig EB, Ivy DD, Widlitz A, et al. (2005) Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 46:697-704
10. Sitbon O, Beghetti M, Petit J, et al. (2006) Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. Eur J Clin Invest 36(Suppl 3):25-31
11. Vincent JA, Ross RD, Kassab J, Hsu JM, Pinsky WW (1993) Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood blow. Am J Cardiol 71:1204-1207
12. Yoshibayashi M, Nishioka K, Nakao K, et al. (1991) Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84:2280-2285